Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
---|
04/23/2008 | EP0763116B2 Recombinant viruses, preparation and use thereof in gene therapy |
04/23/2008 | CN101164623A Compositions comprising viruses and methods for concentrating virus preparations |
04/23/2008 | CN100383250C Method of expressing bird catching arachinid toxin I and its special carrier |
04/23/2008 | CN100383161C Polypeptide for inhibiting gelatin enzyme A activity and its preparation method and application |
04/22/2008 | US7361503 Sequences encoding hepatitis C virus glycoproteins |
04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
04/22/2008 | US7361496 Rescue of mumps virus from cDNA |
04/22/2008 | US7361356 Gene expression in host cell of conformational epitopes; used as elements of diagnostic immunoassay procedures for papillomavirus infection |
04/22/2008 | US7361352 Influenza immunogen and vaccine |
04/22/2008 | CA2353417C Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
04/17/2008 | WO2008043805A1 Medium supplement for virus production |
04/17/2008 | WO2007127264A3 Scalable production method for aav |
04/17/2008 | WO2007084773A3 Enhanced production of infectious parvovirus vectors in insect cells |
04/17/2008 | US20080090918 Macroporous gel; cooling aqueous solution of gel forming polymer and solvent at a temperature which freezes solvent |
04/17/2008 | US20080090282 Use of cell surface displays in yeast cell catalyst supports |
04/17/2008 | US20080090281 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
04/17/2008 | US20080089910 Attenuated Herpes Simplex Virus Type-2, Vectors Thereof and Immunogenic Compositions Thereof |
04/17/2008 | US20080089909 nucleotide sequences encoding HIV-1 Clade A Gag, Pol (RT and Int), and Nef ("GRIN), HIV-1 Clade A Gag, RT and Nef ("GRN") or HIV-1 Clade A Env; generating an immune response against HIV-1 |
04/17/2008 | US20080089908 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
04/17/2008 | US20080089907 Modified vaccinia Ankara virus variant |
04/17/2008 | US20080089864 Viral sequences for targeted replication in tumor cells |
04/17/2008 | US20080089863 Non-Integrative And Non-Replicative Lentivirus , Preparation And Uses Thereof |
04/17/2008 | CA2665603A1 Medium supplement for virus production |
04/17/2008 | CA2665068A1 Methods for treating cancer with mva |
04/16/2008 | EP1911836A1 Medium supplement for virus production |
04/16/2008 | EP1910578A2 Methods and compositions for detecting bk virus |
04/16/2008 | EP1910522A2 Caveolin-3 and in vitro culture of hepatitis c virus |
04/16/2008 | EP1909849A2 Use of mutant herpes simplex virus-2 for cancer therapy |
04/16/2008 | EP1660665B1 Chimaeric vector system |
04/16/2008 | EP1477560B1 ALGA-ORIGIN PROMOTER and INTRON |
04/16/2008 | CN101163714A Influenza nucleic acids, polypeptides, and uses thereof |
04/16/2008 | CN100381565C Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant ibdv strains |
04/15/2008 | US7358075 Infecting cells (serum free media), monitoring viability using flow cytometry open reading frame expression with flourescent antibody cell sorting; Postweaning multisystemic wasting syndrome; rapid, high yield |
04/15/2008 | CA2082155C Swine pneumonia vaccine and method of preparation |
04/10/2008 | WO2008040060A1 Vlp based vaccine delivery system |
04/10/2008 | US20080085545 Compositions comprising viruses and methods for concentrating virus preparations |
04/09/2008 | EP1908822A2 Infectious bursal disease virus mutants and vaccines |
04/09/2008 | EP1908479A2 Anti-p53 Antibodies |
04/09/2008 | EP1907610A2 Secretion of antibodies without signal peptides from bacteria |
04/09/2008 | EP1907537A2 Paramyxoviridae virus preparations |
04/09/2008 | EP1907536A1 Cell line for producing coronaviruses |
04/09/2008 | EP1907535A2 Cdna construct of salmonidae alphavirus |
04/09/2008 | EP1907534A1 Bacteriophage and their uses |
04/09/2008 | EP1907414A2 Parechovirus, vaccines, medicaments and diagnostic kits |
04/09/2008 | EP1228095B1 Modified gp100 and uses thereof |
04/09/2008 | EP1186655B1 Packaging cell |
04/09/2008 | CN100379865C Method and reagents for vaccination which generate a CD8 T cell immune response |
04/09/2008 | CN100379853C Genetic constructs and compositions comprising RRE and CTE and uses thereof |
04/09/2008 | CN100379451C 疫苗 Vaccine |
04/08/2008 | USRE40233 Hepatitus B virus and Hepadnavirus mutant with a single mutation affecting the normal function of the DNA polymerase resulting in decreased sensitivity to a nucleoside analogue such as famciclovir, penciclovir and lamivudine; monitoring antiviral therapy |
04/08/2008 | US7355033 Screening for West Nile Virus antiviral therapy |
04/08/2008 | US7354756 Expression of nucleic acid produces polypeptide which spontaneously splices in host to yield a cyclized form; catalyzes formation of aminosuccinimide; useful in drug screening |
04/08/2008 | US7354591 Poxvirus with targeted infection specificity |
04/08/2008 | US7354190 Two-stage mixing system, apparatus, and method |
04/08/2008 | CA2143104C Phagemids coexpressing a surface receptor and a surface heterologous protein |
04/03/2008 | WO2008039357A2 Uncoupling of dna insert propagation and expression of protein for phage display |
04/03/2008 | WO2008039136A1 Separation matrix for viral purification |
04/03/2008 | WO2008039022A1 Human rotavirus and vaccine composition comprising same |
04/03/2008 | WO2008038641A1 Method of proliferating hepatitis virus, hollow fiber for culturing hepatitis virus-infected cells and utilization of the same |
04/03/2008 | WO2008037504A1 Interleukin-1 muteins linked to virus-like particles to treat il-1 associated diseases |
04/03/2008 | CA2664418A1 Interleukin-1 muteins linked to virus-like particles to treat il-1 associated diseases |
04/02/2008 | EP1905837A1 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
04/02/2008 | EP1905304A2 Treatment of neoplasms with viruses |
04/02/2008 | EP1904627A2 Method for the preparation of prrs virus and proteins of and diagnostic test kits for detecting them |
04/02/2008 | EP1904626A1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications |
04/02/2008 | EP1546313B1 Thermostable rna ligase from thermus phage |
04/02/2008 | CN101155915A Virus purification using ultrafiltration |
04/02/2008 | CN101153280A Method for purifying human papilloma virus advanced protein from prokaryote |
04/02/2008 | CN100378216C 9M-negative EHV-mutants |
04/01/2008 | US7351697 Tumor-specific vector for gene therapy |
04/01/2008 | US7351570 Hepatitis d viral nucleotide sequences for use in diagnosis of hepatitis b infection |
04/01/2008 | US7351533 Recombinant papilloma virions capable of forming conformational antigenic epitopes for use as therapeutic delivery systems; viricides; antitumor agents |
04/01/2008 | US7351527 Isolated avirulent form of a carp virus, a double stranded DNA virus having a capsid with a icosahedron morphology and being of 90-110 nm in size and having 250,000 - 300,000 base pairs; causative agent of the disease affecting Cyprinus carpino; fish vaccines |
04/01/2008 | US7351413 Stabilized HBc chimer particles as immunogens for chronic hepatitis |
04/01/2008 | CA2305623C Porcine circovirus, vaccines, and diagnostic reagents |
03/27/2008 | WO2008034857A1 Pestivirus mutant for use in a vaccine |
03/27/2008 | WO2008034476A1 Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system |
03/27/2008 | WO2008034388A1 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof |
03/27/2008 | WO2008014251A3 Filter assembly for a reprocessor |
03/27/2008 | US20080076904 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
03/27/2008 | US20080076824 Compounds That Inhibit Replication Of Human Immunodeficiency Virus |
03/27/2008 | US20080076173 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
03/27/2008 | US20080076115 Compositions and Methods for Detecting Severe Acute Respiratory Syndrome Coronavirus |
03/27/2008 | US20080075740 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
03/27/2008 | US20080075739 Attenuated Salmonella SP12 Mutants as Antigen Carriers |
03/27/2008 | US20080075737 inducing an immune response to an HIV antigen; genetic engineered polypeptide; inserted into cell; improves or restores the blood clotting time, blood disorders; gene therapy |
03/27/2008 | US20080075736 Materials and methods for respiratory disease control in canines |
03/27/2008 | CA2663443A1 Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system |
03/27/2008 | CA2663142A1 Pestivirus mutant for use in a vaccine |
03/26/2008 | EP1902740A1 Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system |
03/26/2008 | EP1434789B1 Improved protein disaggregation and refolding using high pressure |
03/26/2008 | EP0871482B1 Recombinant vesiculoviruses and their uses |
03/26/2008 | CN101151363A Plant virus designated tomato torrado virus |
03/26/2008 | CN101151272A Recombinant icosahedral virus like particle production in pseudomonads |
03/26/2008 | CN101148661A Human papilloma virus 16 type coat protein virus-like particles, preparation method and use thereof |
03/25/2008 | US7348410 Flea head, nerve cord, hindgut and malpighian tubule proteins |
03/25/2008 | US7348314 Double-stranded ribonucleic acid |
03/25/2008 | US7348177 Expression of HIV polypeptides and production of virus-like particles |
03/25/2008 | US7348134 Cell-free system for translation and formation of HTLV lymphadenopathy associated viral coat proteins; viricides; drug screening |
03/25/2008 | US7348014 Anticancer agents; gene therapy; trimers; host cells; genomes |